331 related articles for article (PubMed ID: 27164704)
1. Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy.
Lemke JR; Geider K; Helbig KL; Heyne HO; Schütz H; Hentschel J; Courage C; Depienne C; Nava C; Heron D; Møller RS; Hjalgrim H; Lal D; Neubauer BA; Nürnberg P; Thiele H; Kurlemann G; Arnold GL; Bhambhani V; Bartholdi D; Pedurupillay CR; Misceo D; Frengen E; Strømme P; Dlugos DJ; Doherty ES; Bijlsma EK; Ruivenkamp CA; Hoffer MJ; Goldstein A; Rajan DS; Narayanan V; Ramsey K; Belnap N; Schrauwen I; Richholt R; Koeleman BP; Sá J; Mendonça C; de Kovel CG; Weckhuysen S; Hardies K; De Jonghe P; De Meirleir L; Milh M; Badens C; Lebrun M; Busa T; Francannet C; Piton A; Riesch E; Biskup S; Vogt H; Dorn T; Helbig I; Michaud JL; Laube B; Syrbe S
Neurology; 2016 Jun; 86(23):2171-8. PubMed ID: 27164704
[TBL] [Abstract][Full Text] [Related]
2. Novel homozygous missense variant of GRIN1 in two sibs with intellectual disability and autistic features without epilepsy.
Rossi M; Chatron N; Labalme A; Ville D; Carneiro M; Edery P; des Portes V; Lemke JR; Sanlaville D; Lesca G
Eur J Hum Genet; 2017 Feb; 25(3):376-380. PubMed ID: 28051072
[TBL] [Abstract][Full Text] [Related]
3. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
[TBL] [Abstract][Full Text] [Related]
4. De novo GRIN1 mutations: An emerging cause of severe early infantile encephalopathy.
Zehavi Y; Mandel H; Zehavi A; Rashid MA; Straussberg R; Jabur B; Shaag A; Elpeleg O; Spiegel R
Eur J Med Genet; 2017 Jun; 60(6):317-320. PubMed ID: 28389307
[TBL] [Abstract][Full Text] [Related]
5. Abnormal circadian rhythm in patients with GRIN1-related developmental epileptic encephalopathy.
Scala M; Amadori E; Fusco L; Marchese F; Capra V; Minetti C; Vari MS; Striano P
Eur J Paediatr Neurol; 2019 Jul; 23(4):657-661. PubMed ID: 31176596
[TBL] [Abstract][Full Text] [Related]
6. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
[TBL] [Abstract][Full Text] [Related]
7. De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.
Fry AE; Fawcett KA; Zelnik N; Yuan H; Thompson BAN; Shemer-Meiri L; Cushion TD; Mugalaasi H; Sims D; Stoodley N; Chung SK; Rees MI; Patel CV; Brueton LA; Layet V; Giuliano F; Kerr MP; Banne E; Meiner V; Lerman-Sagie T; Helbig KL; Kofman LH; Knight KM; Chen W; Kannan V; Hu C; Kusumoto H; Zhang J; Swanger SA; Shaulsky GH; Mirzaa GM; Muir AM; Mefford HC; Dobyns WB; Mackenzie AB; Mullins JGL; Lemke JR; Bahi-Buisson N; Traynelis SF; Iago HF; Pilz DT
Brain; 2018 Mar; 141(3):698-712. PubMed ID: 29365063
[TBL] [Abstract][Full Text] [Related]
8. GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function.
Chen W; Shieh C; Swanger SA; Tankovic A; Au M; McGuire M; Tagliati M; Graham JM; Madan-Khetarpal S; Traynelis SF; Yuan H; Pierson TM
J Hum Genet; 2017 Jun; 62(6):589-597. PubMed ID: 28228639
[TBL] [Abstract][Full Text] [Related]
9. Electroclinical history of a five-year-old girl with GRIN1-related early-onset epileptic encephalopathy: a video-case study.
Pironti E; Granata F; Cucinotta F; Gagliano A; Efthymiou S; Houlden H; Salpietro V; Di Rosa G
Epileptic Disord; 2018 Oct; 20(5):423-427. PubMed ID: 30355546
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation.
Lewis SA; Shetty S; Gamble S; Heim J; Zhao N; Stitt G; Pankratz M; Mangum T; Marku I; Rosenberg RB; Wilfong AA; Fahey MC; Kim S; Myers SJ; Appavu B; Kruer MC
Orphanet J Rare Dis; 2023 Aug; 18(1):225. PubMed ID: 37537625
[TBL] [Abstract][Full Text] [Related]
11. Paradigmatic De Novo
Santos-Gómez A; Miguez-Cabello F; Juliá-Palacios N; García-Navas D; Soto-Insuga V; García-Peñas JJ; Fuentes P; Ibáñez-Micó S; Cuesta L; Cancho R; Andreo-Lillo P; Gutiérrez-Aguilar G; Alonso-Luengo O; Málaga I; Hedrera-Fernández A; García-Cazorla À; Soto D; Olivella M; Altafaj X
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884460
[TBL] [Abstract][Full Text] [Related]
12. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
13. A homozygous GRIN1 null variant causes a more severe phenotype of early infantile epileptic encephalopathy.
Blakes AJM; English J; Banka S; Basu H
Am J Med Genet A; 2022 Feb; 188(2):595-599. PubMed ID: 34611970
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the GABRB2-Associated Neurodevelopmental Disorders.
El Achkar CM; Harrer M; Smith L; Kelly M; Iqbal S; Maljevic S; Niturad CE; Vissers LELM; Poduri A; Yang E; Lal D; Lerche H; Møller RS; Olson HE;
Ann Neurol; 2021 Mar; 89(3):573-586. PubMed ID: 33325057
[TBL] [Abstract][Full Text] [Related]
15. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy.
Lemke JR; Hendrickx R; Geider K; Laube B; Schwake M; Harvey RJ; James VM; Pepler A; Steiner I; Hörtnagel K; Neidhardt J; Ruf S; Wolff M; Bartholdi D; Caraballo R; Platzer K; Suls A; De Jonghe P; Biskup S; Weckhuysen S
Ann Neurol; 2014 Jan; 75(1):147-54. PubMed ID: 24272827
[TBL] [Abstract][Full Text] [Related]
16. Overlapping cortical malformations in patients with pathogenic variants in
Brock S; Laquerriere A; Marguet F; Myers SJ; Hongjie Y; Baralle D; Vanderhasselt T; Stouffs K; Keymolen K; Kim S; Allen J; Shaulsky G; Chelly J; Marcorelle P; Aziza J; Villard L; Sacaze E; de Wit MCY; Wilke M; Mancini GMS; Hehr U; Lim D; Mansour S; Traynelis SF; Beneteau C; Denis-Musquer M; Jansen AC; Fry AE; Bahi-Buisson N
J Med Genet; 2023 Feb; 60(2):183-192. PubMed ID: 35393335
[TBL] [Abstract][Full Text] [Related]
17. GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms.
Ragnarsson L; Zhang Z; Das SS; Tran P; Andersson Å; des Portes V; Desmettre Altuzarra C; Remerand G; Labalme A; Chatron N; Sanlaville D; Lesca G; Anggono V; Vetter I; Keramidas A
Epilepsia; 2023 Dec; 64(12):3377-3388. PubMed ID: 37734923
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
19. De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.
Palmer EE; Stuhlmann T; Weinert S; Haan E; Van Esch H; Holvoet M; Boyle J; Leffler M; Raynaud M; Moraine C; van Bokhoven H; Kleefstra T; Kahrizi K; Najmabadi H; Ropers HH; Delgado MR; Sirsi D; Golla S; Sommer A; Pietryga MP; Chung WK; Wynn J; Rohena L; Bernardo E; Hamlin D; Faux BM; Grange DK; Manwaring L; Tolmie J; Joss S; ; Cobben JM; Duijkers FAM; Goehringer JM; Challman TD; Hennig F; Fischer U; Grimme A; Suckow V; Musante L; Nicholl J; Shaw M; Lodh SP; Niu Z; Rosenfeld JA; Stankiewicz P; Jentsch TJ; Gecz J; Field M; Kalscheuer VM
Mol Psychiatry; 2018 Feb; 23(2):222-230. PubMed ID: 27550844
[TBL] [Abstract][Full Text] [Related]
20. Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site.
Kew JN; Koester A; Moreau JL; Jenck F; Ouagazzal AM; Mutel V; Richards JG; Trube G; Fischer G; Montkowski A; Hundt W; Reinscheid RK; Pauly-Evers M; Kemp JA; Bluethmann H
J Neurosci; 2000 Jun; 20(11):4037-49. PubMed ID: 10818139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
